About the Course

The 2025 Fundamentals of HCT Training Course is a two-day course that will be held virtually on Thursday, April 3 - Friday, April 4, 2025.

The Fundamentals of HCT Training Course provides a broad overview and introduction of hematopoietic cell transplantation (HCT) and cellular immunotherapy (CI). Throughout the lectures, participants are introduced to numerous aspects of the HCT-CI processes, which are designed to develop or enhance skills required in the management of patients undergoing these procedures. This course incorporates case-based learning to emphasize application of concepts taught through didactic lecture with a strong focus on pharmacotherapeutic management. 

Who Should Attend

  • Advanced Practice Providers
  • Fellows
  • In-Training Professionals
  • New Practitioners
  • Pharmacists
  • Physicians
  • Nurses
  • Residents

Key Information

  • Deadline to register: April 2, 2025 at 5 PM CT
  • Attendees can earn up to 14.5 CE for sessions attended in real-time
  • Access session recordings through May 4, 2025

Registration

Registration Rates
Type Price
ASTCT Member Rate $350
Non-Member Rate $450
Fellow/Trainee Rate $300
Low-Middle Income Countries Rate* $15
Preorder of the 2025 Fundamentals of HCT eBook* $150 (member rate)
$250 (non-member rate)

REGISTER

*Only eligible for registrants currently practicing and residing in a low-middle income country as classified by the World Bank here.

*With this add-on, you will receive access to the 2025 Fundamentals of HCT eBook that will be released in summer 2025. Please advise that the eBook is NOT required to attend the meeting or participate in any of the live sessions.

Attendees will have access to the virtual platform until May 4, 2025, to review recordings, but please note that to obtain ACPE credit, AMA PRA Category 1 Credit(s), and ANCC contact hours, you must attend the live sessions on April 3-4, 2025. Recordings are only available to view on the virtual platform. Attendees are unable to download the session recordings for personal viewing, but you will be able to download PDFs of speaker slides. Please review the full accreditation information at the bottom of this page for instructions on participation and requesting credit.

Cancellation Policy

Registered attendees will have access to the recordings until May 4, 2025. Therefore, ASTCT will not be refunding any registrations to the 2025 Fundamentals of HCT Training Course. Registration payments are non-transferable.

Agenda

Day 1: Thursday, April 3, 2025 (CDT)
Time Topic
8:00 – 8:10 AM
(10 mins)		 Welcome & Opening Remarks
Kendall Shultes, PharmD, BCOP; Dept of Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN
8:10 – 8:40 AM
(30 mins)		 Introduction to Hematopoietic Cell Transplantation
Jason Ernstberger, PharmD, BCOP; University of Cincinnati Medical Center, Cincinnati, OH
8:45 – 9:30 AM
(45 mins)		 Donor Selection and Introduction to HLA Typing
Marco Ruiz, MD; Baptist Health Miami Cancer Institute, Miami, FL
9:35 – 10:05 AM
(30 mins)		 Hematopoietic Stem Cell Mobilization
Erika Wass, PharmD, BCOP; Loma Linda University Medical Center, Loma Linda, CA
10:05 – 10:15 AM
(10 mins)		 Break
10:15 – 11:15 AM
(60 mins)		 Principles of Conditioning in Hematopoietic Cell Transplantation
Binni Kunvarjee, PharmD, BCOP; Memorial Sloan Kettering Cancer Center, New York, NY
11:20 – 12:20 PM
(60 mins)		 Supportive Care for Peri-Transplant Complications
Amber Clemmons, PharmD, BCOP, FHOPA; Wellstar-MCG Health Medical Center, Augusta, GA
12:20 – 12:40 PM
(20 mins)		 Lunch
12:40 – 1:25 PM
(45 mins)		 Thrombotic Microangiopathy in Hematopoietic Cell Transplantation
Hemalatha Rangarajan, MD; Nationwide Children's Hospital, Columbus, OH		 Pulmonary Complications of Hematopoietic Cell Transplantation
Samuel Goldfarb, MD; University of Minnesota Masonic Children’s Hospital, Minneapolis, MN
1:30 – 2:15 PM
(45 mins)		 Veno-Occlusive Disease / Sinusoidal Obstructive Syndrome
Teresa Rushing, PharmD, BCPS, BCOP; Children’s Hospital Los Angeles, Los Angeles, CA
2:15 – 2:25 PM
(10 mins)		 Break
2:25 – 3:25 PM
(60 mins)		 Immune Effector Cell Products and Indications
Jennifer Collins, PharmD, BCOP; University of Chicago Medicine, Chicago, IL
3:30 – 4:30 PM
(60 mins)		 Immune Effector Cell Management of Toxicities and Complications
Cameron Ninos, PharmD, BCOP; University of Wisconsin–Madison, Madison, WI
4:30 – 5:00 PM
(30 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)
Day 2: Friday, April 4, 2025 (CDT)
Time Topic
8:00 – 9:00 AM
(60 mins)		 Fungal Infections in Hematopoietic Cell Transplantation
Arpita Gandhi, PharmD, BCOP; Emory Healthcare Winship Cancer Institute, Atlanta, GA
9:05 – 10:05 AM
(60 mins)		 Viral Infections in Hematopoietic Cell Transplantation
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA; Wake Forest University, Winston-Salem, NC
10:05 – 10:15 AM
(10 mins)		 Break
10:15 – 11:15 AM
(60 mins)		 Special Populations in HCT: Pediatrics
Susie Long, PharmD; University of Minnesota Masonic Children’s Hospital, Minneapolis, MN		 Special Populations in HCT: Geriatrics
Andrew Artz, MD, MS; City of Hope, Duarte, CA
11:25 – 12:40 PM
(75 mins)		 Acute Graft versus Host Disease
Elizabeth DiMaggio, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
12:40 – 1:00 PM
(20 mins)		 Lunch
1:00 – 2:15 PM
(75 mins)		 Chronic Graft versus Host Disease
Rebecca Gonzalez, PharmD, BCOP; Moffitt Cancer Center, Tampa, FL
2:15 – 2:25 PM
(10 mins)		 Break
2:25 – 3:10 PM
(45 mins)		 Maintenance Strategies after Hematopoietic Cell Transplantation
Mary McGann, PharmD, BCOP; Medical University of South Carolina, Charleston, SC
3:15 – 4:15 PM
(60 mins)		 Long Term Complications and Survivorship in Hematopoietic Cell Transplantation
Ila Saunders, PharmD, BCOP; UC San Diego Skaggs School of Pharmacy, San Diego, CA
4:15 – 4:45 PM
(30 mins)		 Virtual Roundtable Discussion & Wrap-Up (*No CE provided)

Accredited Provider

This activity is jointly provided by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). Attendees can earn up to 14.5 continuing education credits or hours.

 

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the American Society for Transplantation and Cellular Therapy (ASTCT). The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION

The France Foundation designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSES

The France Foundation designates this activity for 14.5 contact hours.

PHARMACISTS

This knowledge and application-based activity qualifies for 14.5 contact hours (0.145 CEUs) of continuing pharmacy education credit. Please submit all evaluations and credit requests no later than 30 days after you complete this activity to ensure your credit fulfillment, as CE credit cannot be awarded past 60 days from the activity date. Your CE credits will be electronically submitted to the NABP upon successful completion of the activity. Pharmacists with questions can contact NABP customer service (custserv@nabp.net)

All other healthcare professionals completing this course will be issued a statement of participation.

COURSE SYLLABUS

The course syllabus will be available closer to the course dates. 

DISCLOSURE POLICY
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TFF and ASTCT resolve all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all their educational programs. Furthermore, TFF and ASTCT seek to verify that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. TFF and ASTCT are committed to providing learners with high-quality CE activities that promote improvements in health care and not those of a commercial interest.

Disclosures for members of the planning committee and faculty will be made available closer to the course dates.

Disclosure of Unlabeled Use:
The France Foundation (TFF) and The American Society for Transplantation and Cellular Therapy (ASTCT) require CE faculty (speakers) to disclose when products or procedures being discussed are off label, unlabeled, experimental, and/or investigational. They must also disclose limitations on the information that is presented, such as data that are preliminary, or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off label use of these medications. TFF and ASTCT do not recommend the use of any agent outside of the labeled indications. If you have questions, contact the Medical Affairs Department of the manufacturer for the most recent prescribing information.

COMMERCIAL SUPPORT ACKNOWLEDGMENT

ASTCT is not seeking commercial support to assist in funding this live education opportunity.

Disclaimer
The France Foundation and the American Society for Transplantation and Cellular Therapy present this information for educational purposes only. The content is provided solely by faculty who have been selected because of recognized expertise in their field. Participants have the professional responsibility to ensure that products are prescribed and used appropriately on the basis of their own clinical judgment and accepted standards of care. The France Foundation, The American Society for Transplantation

CONTACT INFORMATION
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or info@francefoundation.com.